Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Accelerated Formulation Case Study Released

The challenge for Arcinova was to develop in a short space of time an injectable aqueous solution formulation: The drug substance was thought to be completely insoluble in water so background (client supplied) information was minimal as they had never prepared a liquid formulation of this particular drug substance before. The target formulation concentration was very low (<10 µg/mL).

Find out more here

#CaseStudy #DrugProduct


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.